AKRO logo

Akero Therapeutics, Inc. (AKRO)

Profile

Full Name

Akero Therapeutics, Inc.

Ticker

NASDAQ: AKRO

Exchange

NASDAQ

Country

United States

IPO

June 20, 2019

Indexes

Not included

Employees

69

Key Details

Price

$44.72(+1.57%)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-$3.75(-29.76% YoY)

Next earnings date

Nov 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
See Full Chart & Historical Data

Analyst ratings

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Aug 4, 25 TD Cowen
Buy
May 27, 25 B of A Securities
Buy
May 13, 25 Citigroup
Buy
Mar 3, 25 HC Wainwright & Co.
Buy
Jan 31, 25 UBS
Buy
Jan 30, 25 B of A Securities
Buy
Jan 27, 25 HC Wainwright & Co.
Buy
Jan 16, 25 HC Wainwright & Co.
Buy
Nov 18, 24 HC Wainwright & Co.
Buy
Nov 18, 24 Citigroup
Buy

Institutional Ownership

  • What is the ticker symbol for Akero Therapeutics, Inc.?
  • Does Akero Therapeutics, Inc. pay dividends?
  • What sector is Akero Therapeutics, Inc. in?
  • What industry is Akero Therapeutics, Inc. in?
  • What country is Akero Therapeutics, Inc. based in?
  • When did Akero Therapeutics, Inc. go public?
  • Is Akero Therapeutics, Inc. in the S&P 500?
  • Is Akero Therapeutics, Inc. in the NASDAQ 100?
  • Is Akero Therapeutics, Inc. in the Dow Jones?
  • When was Akero Therapeutics, Inc.'s last earnings report?
  • When does Akero Therapeutics, Inc. report earnings?

What is the ticker symbol for Akero Therapeutics, Inc.?

The ticker symbol for Akero Therapeutics, Inc. is NASDAQ:AKRO

Does Akero Therapeutics, Inc. pay dividends?

No, Akero Therapeutics, Inc. does not pay dividends

What sector is Akero Therapeutics, Inc. in?

Akero Therapeutics, Inc. is in the Healthcare sector

What industry is Akero Therapeutics, Inc. in?

Akero Therapeutics, Inc. is in the Biotechnology industry

What country is Akero Therapeutics, Inc. based in?

Akero Therapeutics, Inc. is headquartered in United States

When did Akero Therapeutics, Inc. go public?

Akero Therapeutics, Inc.'s initial public offering (IPO) was on June 20, 2019

Is Akero Therapeutics, Inc. in the S&P 500?

No, Akero Therapeutics, Inc. is not included in the S&P 500 index

Is Akero Therapeutics, Inc. in the NASDAQ 100?

No, Akero Therapeutics, Inc. is not included in the NASDAQ 100 index

Is Akero Therapeutics, Inc. in the Dow Jones?

No, Akero Therapeutics, Inc. is not included in the Dow Jones index

When was Akero Therapeutics, Inc.'s last earnings report?

Akero Therapeutics, Inc.'s most recent earnings report was on August 8, 2025

When does Akero Therapeutics, Inc. report earnings?

The next expected earnings date for Akero Therapeutics, Inc. is November 7, 2025
On this page